Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Access to Chimeric Antigen Receptor T Cell Clinical Trials in Underrepresented Populations: A Multicenter Cohort Study of Pediatric and Young Adult Acute Lymphobastic Leukemia Patients

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.03.022Source: DataRank Database

Access to Chimeric Antigen Receptor T Cell Clinical Trials in Underrepresented Populations: A Multicenter Cohort Study of Pediatric and Young Adult Acute Lymphobastic Leukemia Patients is a research paper published in Transplantation and Cellular Therapy (2023). On theSindex it has a DataRank of 0. It has been cited 30 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access30 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 3.42)OA: greenTopics (49)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Lena E. Winestone ORCID,Erin Sullivan ORCID,Qian Wu ORCID,Adam J. Lamble ORCID,Mark C. Walters ORCID

Live enrichment

PubMed:36966871 PMC:PMC10247402 OpenAlex:https://openalex.org/W4360860829

National Center for Advancing Translational Sciences

Grant: U01TR002487

National Institutes of Health

Grant: UL1 TR002319

FWCI

3.42

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

greenLicense: cc-by-nc-nd

repositoryhttps://escholarship.org/content/qt7mn70866/qt7mn70866.pdf?t=rxszzl

publisherhttps://api.elsevier.com/content/article/PII:S2666636723011983?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666636723011983?httpAccept=text/plain

repositoryhttps://escholarship.org/uc/item/7mn70866

Fields of Study

CAR-T cell therapy researchAcute Lymphoblastic Leukemia researchChildhood Cancer Survivors' Quality of LifeAdolescentAdultChildChild, PreschoolHumansInfantInfant, NewbornYoung AdultEthnicityLeukemia, Myeloid, AcuteMinority GroupsPrecursor Cell Lymphoblastic Leukemia-LymphomaReceptors, Chimeric AntigenRetrospective StudiesT-LymphocytesClinical Trials as Topic

MeSH Terms

Receptors, Chimeric AntigenAdolescentAdultChildChild, PreschoolClinical Trials as TopicEthnicityHumansInfantInfant, NewbornMinority GroupsRetrospective StudiesT-LymphocytesLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaYoung Adult

Keywords

MedicineClinical trialChimeric antigen receptorCohortPediatricsInternal medicineCancerImmunotherapyPediatricClinical TrialsAccess To CareB-allDisparitiesCar-t Cells

Sustainable Development Goals

SDG 0: Partnerships for the goals

Access to Chimeric Antigen Receptor T Cell Clinical Trials in Underrepresented Populations: A Multicenter Cohort Study of Pediatric and Young Adult Acute Lymphobastic Leukemia Patients

FAIR Checklist

Authors (15)

Funding (2 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)